Ownership Summary
A total of 3 institutions have reported a stake in ENDRA Life Sciences Inc. (NASDAQ:NDRA) as of December 2025, according to recent 13F filings with the SEC.
- Institutional ownership in ENDRA Life Sciences edged down to 1.7% in December 2025, compared to 1.7% in September 2025.
- Quarterly data indicates a 9143.26% shift in institutional share volume, and the annual owner count reflects a decrease of 25.00%.
- A review of institutional activity for ENDRA Life Sciences shows 2 of 3 filers increasing their positions, while 1 reduced their stake, and 0 remained unchanged.
- Collectively, institutional investors increased their stake in ENDRA Life Sciences to 13.03K shares as of December 2025, a change that is up by 12.89K shares quarter on quarter and up 12.92K shares year over year.
- The top institutional stake in ENDRA Life Sciences as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 12.94K shares, or 1.70% of the company.
- Among the most significant buyers of ENDRA Life Sciences during December 2025 were VANGUARD GROUP INC (12.94K), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (49).
- Leading sellers of ENDRA Life Sciences stock in December 2025 included UBS Group AG (94).
- The top 3 institutional holders of ENDRA Life Sciences for the quarter ending December 2025 included VANGUARD GROUP INC (12.94K), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (84), UBS Group AG (12).